Table-3 Comparison of IPSS, NIH-CPSI and IIEF-5 scores in patients with and without prostatic calcification after treatment,

From: Prospective Study on Association of Prostatic Calcifications with Clinical Symptoms and Results of Treatment in Men with type III prostatitis

variables

CP with PC (n = 121)

CP without PC (n = 151)

0 week

4 weeks

8 weeks

12 weeks

0 week

4 weeks

8 weeks

12weeks

IPSS

15.6 ± 6.6

15.4 ± 6.1

15.8 ± 5.8

12.5 ± 4.7*

15.3 ± 7.0

14.3 ± 6.2

12.8 ± 5.2*

11.8 ± 4.8

NIH-CPSI

23.3 ± 7.1

23.0 ± 6.6

21.5 ± 6.0*

18.5 ± 5.3

23.1 ± 6.9

22.9 ± 6.5

19.1 ± 6.2*

17.0 ± 5.8

IIEF-5

15.8 ± 4.7

15.9 ± 4.3

16.2 ± 4.1

16.7 ± 4.1

15.7 ± 4.8

15.8 ± 4.7

16.4 ± 4.4

18.3 ± 4.3*

WBC

7.7 ± 12.8

7.6 ± 11.3

6.7 ± 8.8

6.9 ± 8.6

3.9 ± 4.7

3.9 ± 4.7

3.5 ± 3.7

2.9 ± 2.7

  1. CP = chronic prostatitis; PC = prostate calification; IPSS = international prostate symptom score; NIH-CPSI = National Institutes of Health Chronic Prostatitis Symptom Index; IIEF = International Index of Erectile Function
  2. WBC = white blood cell.
  3. The analysis of variance and paired t-test were used to analyze characteristics. Categorical variables were compared using the Pearson chi-square test. P < 0.05 was considered statistically significant. The result were compared with the a base line 0 week time point groups before treatment.Data are presented as means ± standard deviation(*P < 0.05)
Back to article page